Browser Warning
VHBio is not supported on Internet Explorer and will not provide you with the best experience. Please consider switching to a compatible browser such as Microsoft Edge, Google Chrome or Firefox.
We genuinely believe in what we do and want to be the best life sciences supply partner. Any information to help our journey is very welcome. Please take a few minutes to help us improve and make your future experiences better:
The HEY human ovarian carcinoma cell line was derived from a human ovarian cancer xenograft (HX-62) originally grown from a peritoneal deposit of a patient with moderately differentiated papillary cystadenocarcinoma of the ovary. The cell line has demonstrated differential ability to grow in semisolid culture and as a xenograft in immunologically deprived CBA/CJ mice. The […]
The HEY human ovarian carcinoma cell line was derived from a human ovarian cancer xenograft (HX-62) originally grown from a peritoneal deposit of a patient with moderately differentiated papillary cystadenocarcinoma of the ovary. The cell line has demonstrated differential ability to grow in semisolid culture and as a xenograft in immunologically deprived CBA/CJ mice. The HEY cell line shows a degree of resistance to the alkylating agent cis-diamminedichloroplatinum(II) (cis-platinum).
| Product | Units |
|---|---|
|
Human Ovarian Cancer Cell Line (HEY) CLU302 |
1 Ml |
We work with a range of suppliers with novel and innovative products sourced from our global partners.
Find Products